Search results
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 5 days ago“We are proud to make SIMLANDI available in the U.S. to...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 4 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 4 days agoTakeaway Humira was one of the first biologic medications approved for psoriatic arthritis in 2005...
Bristol-Myers Squibb (NYSE:BMY) Shares Down 1.1%
ETF DAILY NEWS· 5 hours agoShares of Bristol-Myers Squibb (NYSE:BMY – Get Free Report) fell 1.1% during trading on Thursday . The company traded as low as $41.58 and last traded at $41.89. 3,501,801 shares changed hands ...
Jump Financial LLC Has $369,000 Stock Position in Acelyrin, Inc. (NASDAQ:SLRN)
ETF DAILY NEWS· 9 hours agoJump Financial LLC lifted its stake in shares of Acelyrin, Inc. (NASDAQ:SLRN – Free Report) by 152.7% during the fourth quarter, according to the company in its most recent filing with the Securities ...
What To Know and Do About Arthritis Pain
Health via Yahoo News· 7 days agoArthritis is a condition that causes pain, stiffness, and inflammation in your joints. Fortunately, medications and home remedies can help relieve pain.
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 5 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
AbbVie (NYSE:ABBV) Shares Down 0.1%
ETF DAILY NEWS· 5 hours agoAbbVie Inc. (NYSE:ABBV – Get Free Report)’s stock price dropped 0.1% during mid-day trading on Thursday . The stock traded as low as $157.76 and last traded at $159.38. Approximately 903,885 ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 12 hours agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.
ETF DAILY NEWS· 5 days agoPanagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...
